Authors

• Nick H. Kim (ORCID: https://orcid.org/0000-0003-4702-650X)
• Stefano Turricchia
• Vallerie V. McLaughlin (ORCID: https://orcid.org/0000-0002-8907-1651)
• Richard N. Channick (ORCID: https://orcid.org/0000-0002-9016-4468)
• Kelly Chin (ORCID: https://orcid.org/0000-0002-1214-6723)
• Nicolas Martin (ORCID: https://orcid.org/0000-0001-9084-9435)
• Lada Mitchell
• Rose Ong (ORCID: https://orcid.org/0009-0005-0606-603X)

Institutions

• University of California, Los Angeles (US)
• University of Michigan (US)
• University of California San Diego (US)
• Johnson & Johnson (Switzerland) (CH)
• Southwestern Medical Center (US)
• Southwestern Medical Center (US)
• The University of Texas Southwestern Medical Center (US)
• Actelion (Switzerland) (CH)

Publication Details

Journal

Cardiology and Therapy

Published

2024-11-25

DOI

https://doi.org/10.1007/s40119-024-00386-1

Citations

2

Primary Topic

Pulmonary Hypertension Research and Treatments

Type

article

Field-Weighted Citation Impact

0.84

Funders

• Actelion Pharmaceuticals